Overview:
Albumin is the predominant protein in plasma. Albumin’s
principle function is the maintenance of colloid oncotic
pressure (COP), helping retain water and electrolytes
inside the intravascular space. Maintenance of adequate
COP prevents edema formation within the interstitium,
the gastrointestinal tract, and the lungs. Albumin
also serves as an important carrier molecule for hormones,
calcium, magnesium, fatty acids, and many of the administered
drugs.
Many diseases including sepsis, end stage liver disease,
burns, and protein losing
nephropathies and enteropathies can result in severe
hypoalbuminemia. The resulting low COP promotes extravasation
of intravascular fluids, interstitial edema and decreased
tissue perfusion and tissue ischemia. Ultimately,
hypoalbuminemia is associated with increased morbidity
and mortality in critical patients.
Historically veterinarians have tried to combat the
loss of intravascular albumin and COP through the
use of plasma and synthetic colloids. Currently there
is a commercially available species-specific freeze
dried canine albumin solution that appears to be relatively
safe and effective at partially replenishing albumin
and maintaining COPs in hypoalbuminemic patients.
Target end points for albumin transfusion attaining
2g/dL serum albumin concentration or clinical improvement
of edema or third spacing.
The following chart highlights the advantages and
disadvantages of different sources of albumin available
for dogs:
References
- “Plasma Therapy with Macromolecular Plasma
Volume Expanders”, in Fluid, Electrolyte,
and Acid Base Disorders, 3rd Edition, DiBartola,
2006, pp 621-634
- ‘The role of albumin replacement in the
critically ill veterinary patient”. Mazzaferro
et al. Journal of Veterinary Emergency and Critical
Care 12(2) 2002. pp 113-124
- Canine Albumin, Lyophilized. Animal Blood Resources
International product information handout.
Product |
Albumin concentration |
Advantages |
Disadvantages |
Equivalent doses
required to increase serum albumin by 0.5g/dL |
Equivalent volume
of administration to increase serum albumin
by 0.5g/dL in a 30Kg (66lb) dog. |
Whole Blood |
˜ 12g-18g albumin/L |
Provision of Albumin + RBCs
+PLTs +Coagulation factors+ ATIII |
Availability+ Expense +
Increased blood viscosity if patient not anemic
before transfusion + Extremely large volumes
required
|
37.5ml/Kg |
1,100ml |
Fresh Frozen Plasma |
˜ 30g albumin/L |
Provision of Albumin +Coagulation
factors+ ATIII |
Availability + Expense +Very
Large Volumes required |
22.5ml/Kg |
675ml |
HSA |
250g albumin /L |
Long shelf life +
Concentrated source of albumin
|
High Antigenic potential
+
Potential for intravascular volume overload
|
2.7ml/Kg |
81ml |
Lyophilized K9 Albumin |
160g albumin/L |
Long shelf life +
Concentrated source of species-specific albumin
|
No available research on
potential long-term complications + Potential
for intravascular volume overload |
4.2ml/Kg |
126ml |
|